Low temperature incubation improves the performance of anti-phenolic glycolipid-I antibody detecting ELISA in leprosy patients

References

1. Buhrer, S. S., Smits, H. L., Gussenhoven, G. C., van Ingen, C. W. & Klatser, P. R. ( 1998; ). A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae. Am J Trop Med Hyg 58, 133–136.
   [Google Scholar]
2. Chanteau, S., Cartel, J. L., Celerier, P., Plichart, R., Desforges, S. & Roux, J. ( 1989; ). PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy. Int J Lepr Other Mycobact Dis 57, 735–743.
   [Google Scholar]
3. Chanteau, S., Glaziou, P., Plichart, C., Luquiaud, P., Plichart, R., Faucher, J. F. & Cartel, J. L. ( 1993; ). Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10-year prospective field study in French Polynesia. Int J Lepr Other Mycobact Dis 61, 533–541.
   [Google Scholar]
4. Cho, S. N., Yanagiriha, D., Hunter, S. W., Gelber, R. H. & Brennan, P. J. ( 1983; ). Serological specificity of phenolic glycolipid-I from Mycobacterium leprae and use in serodiagnosis of leprosy. Infect Immun 41, 1077–1083.
   [Google Scholar]
5. Cho, S. N., Cellona, R. V., Fajardo, T. T., Jr, Abalos, R. M., de la Cruz, E. C., Walsh, G. P., Kim, J. D. & Brennan, P. J. ( 1991; ). Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens. Int J Lepr Other Mycobact Dis 59, 25–31.
   [Google Scholar]
6. Fujiwara, T., Hunter, S. W., Cho, S. N., Aspinall, G. O. & Brennan, P. J. ( 1984; ). Chemical synthesis and serology of disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy. Infect Immun 43, 245–252.
   [Google Scholar]
7. Hunter, S. W. & Brennan, P. J. ( 1981; ). A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J Bacteriol 147, 728–735.
   [Google Scholar]
8. Hussain, R., Jamil, S., Kifayet, A., Firdausi, F., Dockrell, H. M., Lucas, S. & Hasan, R. ( 1990; ). Quantitation of IgM antibodies to the M. leprae synthetic disaccharide can predict early bacterial multiplication in leprosy. Int J Lepr Other Mycobact Dis 58, 491–502.
   [Google Scholar]
9. Parkash, O., Kumar, A., Nigam, A., Franken, K. L. M. C. & Ottenhoff, T. H. M. ( 2006; ). Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients. Scand J Immunol 64, 450–455.[CrossRef]
   [Google Scholar]
10. Roche, P. W., Britton, W. J., Failbus, S. S., Theuvenet, W. J., Lavender, M. & Adiga, R. B. ( 1991; ). Serological responses in primary neuritic leprosy. Trans R Soc Trop Med Hyg 85, 299–302.[CrossRef]
    [Google Scholar]
11. Saad, M. H., Medeiros, M. A., Gallo, M. E., Gontijo, P. P. & Fonseca, L. S. ( 1990; ). IgM immunoglobulins reacting with the phenolic glycolipid-1 antigen from Mycobacterium leprae in sera of leprosy patients and their contacts. Mem Inst Oswaldo Cruz 85, 191–194.[CrossRef]
    [Google Scholar]
12. World Health Organization ( 1988; ). WHO expert committee on leprosy. World Health Organ Tech Rep Ser 678, 1–51.
    [Google Scholar]
13. World Health Organization ( 1998; ). WHO expert committee on leprosy. World Health Organ Tech Rep Ser 874, 1–43.
    [Google Scholar]